Alice Y. Yam, Ph.D.
Affiliations: | 2005 | Stanford University, Palo Alto, CA |
Area:
Biology and of GeneticsGoogle:
"Alice Yam"Mean distance: 26716.5
Parents
Sign in to add mentor| Judith Frydman | grad student | 2005 | Stanford | |
| (De novo folding networks and the substrate spectrum of the eukaryotic chaperonin TRiC /CCT.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Abrahams C, Krimm S, Li X, et al. (2019) Abstract NT-090: PRECLINICAL ACTIVITY AND SAFETY OF STRO-002, A NOVEL ADC TARGETING FOLATE RECEPTOR ALPHA FOR OVARIAN AND ENDOMETRIAL CANCER Clinical Cancer Research. 25 |
| Abrahams CL, Li X, Embry M, et al. (2018) Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001. Oncotarget. 9: 37700-37714 |
| Li X, Abrahams C, Zhou S, et al. (2018) Abstract 1782: Discovery and activity of STRO-002, a novel ADC targeting folate receptor alpha for ovarian and endometrial cancer Cancer Research. 78: 1782-1782 |
| Yin G, Stephenson HT, Yang J, et al. (2017) RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates. Scientific Reports. 7: 3026 |
| Yu A, Abrahams C, Embry M, et al. (2017) High Frequency of CD74 Expression in B-Cell Non-Hodgkin's Lymphoma (NHL) and Targeting with SΤRO-001, a Novel Anti-CD74 Antibody Drug Conjugate (ADC) with Potent I n Vitro Cytotoxicty and In Vivo Anti-Tumor Activity Blood. 130: 573-573 |
| Embry M, Li X, Yu A, et al. (2017) CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, SΤRO-001 Blood. 130: 4420-4420 |
| Abrahams C, Li X, DeAlmeida V, et al. (2017) Abstract 67: Characterization and preclinical development of STRO-001, a novel CD74-targeting antibody-drug conjugate (ADC) for the treatment of B-cell malignancies Cancer Research. 77: 67-67 |
| Li X, Abrahams C, Embry M, et al. (2016) Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL) Blood. 128: 464-464 |
| Abrahams C, Li X, Yu A, et al. (2016) Discovery and Preclinical Development of Novel CD74-Targeting Antibody-Drug Conjugates (ADCs) with Significant Activity in Multiple Myeloma (MM) Cell Lines and Xenograft Models Blood. 128: 4465-4465 |
| Groff D, Armstrong S, Rivers PJ, et al. (2014) Engineering toward a bacterial "endoplasmic reticulum" for the rapid expression of immunoglobulin proteins. Mabs. 6: 671-8 |